Crosspoint Financial’s Direxion HCM Tactical Enhanced US ETF HCMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.55M Buy
44,158
+2
+0% +$76 3.9% 5
2025
Q4
$1.7M Sell
44,156
-798
-2% -$30.7K 4.01% 5
2025
Q3
$1.69M Buy
44,954
+2,404
+6% +$83.2K 4.14% 5
2025
Q2
$1.39M Buy
42,550
+1,937
+5% +$55.3K 3.71% 5
2025
Q1
$1.23M Buy
+40,613
New +$1.44M 3.55% 5

Other funds holding HCMT

Crosspoint Financial's HCMT Position: Q1 2026 in Review

Crosspoint Financial increased its Direxion HCM Tactical Enhanced US ETF (HCMT) stake by 0% in Q1 2026, buying an estimated $76 and bringing the position to 44,158 shares worth $1.55M. The position accounts for 3.9% of the portfolio, ranked #5.

Crosspoint Financial first reported a position in HCMT in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.7M in Q4 2025. 36 funds tracked by Wall St. Rank hold HCMT as of Q1 2026.

  • Crosspoint Financial held 44,158 shares of Direxion HCM Tactical Enhanced US ETF worth $1.55M as of Q1 2026.
  • Crosspoint Financial bought 2 Direxion HCM Tactical Enhanced US ETF shares in Q1 2026, an estimated $76.
  • Direxion HCM Tactical Enhanced US ETF made up 3.9% of Crosspoint Financial's portfolio in Q1 2026, its #5 holding.
  • Crosspoint Financial first reported a position in Direxion HCM Tactical Enhanced US ETF in Q1 2025 and has held it in 5 quarters since.
  • Crosspoint Financial's Direxion HCM Tactical Enhanced US ETF position peaked at $1.7M in Q4 2025.
  • 36 funds tracked by Wall St. Rank held Direxion HCM Tactical Enhanced US ETF as of Q1 2026.

Based on Crosspoint Financial's 13F filing for Q1 2026, filed 13 May 2026.